Looking beyond the leukemic cell for answers
Christopher Pepper et al.
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Why daratumumab will become key for the treatment of multiple myeloma
How far are we from a cure for CLL?
Updates from the CLL14 and CLL2-GiVe trials on CLL